WASHINGTON, July 30 -- The U.S. Department of Veterans Affairs issued the following news release: * * * VA launches trial of GLP-1 treatment for alcohol use disorder * WASHINGTON -The U.S. Department of Veterans Affairs today announced a new clinical trial to evaluate the efficacy of semaglutide, a GLP-1 receptor agonist used to treat diabetes, as treatment for alcohol use disorder (AUD). Currently, more than 400,000 Veterans nationwide are diagnosed with AUD, and some estimates say AUD aff  more